UroGen Pharma Ltd. Shares Outstanding (Cover Page)
UroGen Pharma Ltd. (URGN) had Shares Outstanding (Cover Page) of 48.88 million shares as of 2026-07-28, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-28: Entity Common Stock, Shares Outstanding 48.88M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 48.72M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 48.68M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 46.81M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 48.88M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 48.72M shares 10-Q · filed 2026-05-06 |
| 2026-02-24 | 48.68M shares 10-K · filed 2026-03-02 |
| 2025-10-31 | 46.81M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 46.26M shares 10-Q · filed 2025-08-07 |
| 2025-05-05 | 46.11M shares 10-Q · filed 2025-05-12 |
| 2025-04-23 | 46.11M shares 10-K/A · filed 2025-04-30 |
| 2025-03-03 | 46.09M shares 10-K · filed 2025-03-10 |
| 2024-11-01 | 42.20M shares 10-Q · filed 2024-11-06 |
| 2024-08-05 | 42.11M shares 10-Q · filed 2024-08-13 |
| 2024-05-08 | 36.13M shares 10-Q · filed 2024-05-13 |
| 2024-04-22 | 36.13M shares 10-K/A · filed 2024-04-29 |
| 2024-03-07 | 34.12M shares 10-K · filed 2024-03-14 |
| 2023-11-07 | 30.87M shares 10-Q · filed 2023-11-14 |
| 2023-08-07 | 30.28M shares 10-Q · filed 2023-08-10 |
| 2023-05-08 | 23.45M shares 10-Q · filed 2023-05-11 |
| 2023-04-24 | 23.45M shares 10-K/A · filed 2023-05-01 |
| 2023-03-20 | 23.44M shares 10-K · filed 2023-03-24 |
| 2022-11-07 | 23.09M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 22.74M shares 10-Q · filed 2022-08-11 |
| 2022-05-03 | 22.69M shares 10-Q · filed 2022-05-10 |
| 2022-02-21 | 22.67M shares 10-K · filed 2022-03-21 |
| 2021-11-03 | 22.42M shares 10-Q · filed 2021-11-15 |
| 2021-07-27 | 22.36M shares 10-Q · filed 2021-08-04 |
| 2021-03-31 | 22.28M shares 10-Q · filed 2021-05-13 |
| 2021-02-26 | 22.27M shares 10-K · filed 2021-03-18 |
| 2020-11-04 | 22.09M shares 10-Q · filed 2020-11-09 |
| 2020-08-05 | 22.02M shares 10-Q · filed 2020-08-10 |
| 2020-05-04 | 21.94M shares 10-Q · filed 2020-05-07 |
| 2020-02-19 | 21.15M shares 10-K · filed 2020-03-02 |
| 2019-11-04 | 20.98M shares 10-Q · filed 2019-11-12 |
| 2019-08-05 | 20.90M shares 10-Q · filed 2019-08-09 |
| 2019-05-07 | 20.79M shares 10-Q · filed 2019-05-09 |
| 2019-02-22 | 20.48M shares 10-K · filed 2019-02-28 |
| 2017-12-31 | 13.75M shares 20-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |